- Correction
- Open access
- Published:
Correction to: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells
Journal of Experimental & Clinical Cancer Research volume 39, Article number: 263 (2020)
The Original Article was published on 11 September 2017
Correction to: J Exp Clin Cancer Res 36, 124 (2017)
https://doi.org/10.1186/s13046-017-0590-5
Following publication of the article [1], the authors identified errors in Fig. 7; specifically panels in Fig. 7g (H&E staining of liver and kidney from the control and Sophoridine group). The corrected figure can be found below. The corrections do not change the results or the conclusions of this paper.
Sophoridine inhibits pancreatic cancer cell growth in vivo. a 2 × 106 Miapaca-2 cells were inoculated into Balb/c nude mice. Mice were randomized into three groups (n = 7) and treated with PBS, or Sophoridine at the dose of 20 mg/kg or 40 mg/kg daily for 3 weeks. Tumor volumes were measured by digital caliper every 3 days. b The tumors were excised from mice after last treatment. c Tumor masses were weighed and compared, and each histogram represented the mean ± S.D. d The body weight was measured every week. e The phosphorylation signals of p-ERK, p-JNK and PCNA in xenograft tumor tissues were detected by immunohistochemistry. Apoptosis cells in mice tumor were detected by Tunel staining (f) The liver and kidney biochemical functions were evaluated. The AST, ALT and Cr levels of mouse blood were detected by Elisa assay. g The liver and kidney from control and Sophoridine group were stained with H&E to evaluate the toxicity after treatment. The histological structure of liver and kidney were observed and compared microscopically. h Overview of signaling pathways for Sophoridine-induced cell cycle arrest and apoptosis in human pancreatic tumors
The original article has been updated.
Reference
Xu Z, et al. Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. J Exp Clin Cancer Res. 2017;36:124. https://doi.org/10.1186/s13046-017-0590-5.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Xu, Z., Zhang, F., Bai, C. et al. Correction to: Sophoridine induces apoptosis and S phase arrest via ROS-dependent JNK and ERK activation in human pancreatic cancer cells. J Exp Clin Cancer Res 39, 263 (2020). https://doi.org/10.1186/s13046-020-01764-y
Published:
DOI: https://doi.org/10.1186/s13046-020-01764-y